Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Treg transcriptomic profile in NSG, NSG+Thymus humanized mice and healthy donors (HD)

ABSTRACT: Treg transcriptomic profile in NSG, NSG+Thymus humanized mice and healthy donors (HD)

PROVIDER: PRJNA776635 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16646700.fastq.gz	Fastqsanger.gz
	SRR16646701.fastq.gz	Fastqsanger.gz
	SRR16646702.fastq.gz	Fastqsanger.gz
	SRR16646703.fastq.gz	Fastqsanger.gz
	SRR16646704.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 13

Similar Datasets

Treg transcriptomic profile in NSG, NSG+Thymus humanized mice and healthy donors (HD)

Project description:RNA sequencing was performed on RNA extracted from human Treg cells from NSG, NSG+Thymus humanized mice and healthy donors

2021-11-02 | GSE186881 | GEO

Bone marrow B cell transcriptomic profile in humanized NSG mice injected with KU55933

Project description:RNA Sequencing was performed on RNA extracted from human bone marrow B cells from NSG humanized mice that had been transplanted with human hematopoietic stem cells and then injected or not with the ATM inhibitor KU55933.

2019-11-23 | GSE132963 | GEO

xGVHD in NSG and NSG-HLA-A2/HHD mice

Project description:Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2/HHD mice

| PRJEB26672 | ENA

Whole transcriptome analysis of circulating B cells from multiple sclerosis (MS) patients and healthy donors (HD)

Project description:Whole transcriptome analysis of circulating B cells from multiple sclerosis (MS) patients and healthy donors (HD).

2018-08-01 | GSE117935 | GEO

Bone marrow B cell transcriptomic profile in humanized NSG mice injected with KU55933

Project description:Bone marrow B cell transcriptomic profile in humanized NSG mice injected with KU55933

| PRJNA549586 | ENA

De novo construction of T cell compartment in humanized mice engrafted with iPSC-derived thymus organoids

Project description:Hematopoietic humanized (hu) mice are powerful tools for modeling the action of human immune system and are widely used for preclinical studies and drug discovery. However, generating a functional human T cell compartment in hu mice remains challenging, primarily due to the species-related differences between human and mouse thymus. While engrafting human fetal thymic tissues can support robust T cell development in hu mice, tissue scarcity and ethical concerns limit their wide use. Here, we describe the tissue engineering of human thymus organoids from inducible pluripotent stem cells (iPSC-thymus) that can support the de novo generation of a diverse population of functional human T cells. T cells of iPSC-thymus engrafted hu mice could mediate both cellular and humoral immune responses, including mounting robust proinflammatory responses upon TCR engagement, inhibiting the growth of allogeneic tumor grafts and facilitating efficient Ig class switching. Our findings suggest that hu mice engrafted with iPSC-thymus can serve as a novel animal model to study human T cell-mediated immunity and accelerate the translation of animal studies into the clinic.

2022-05-31 | GSE201675 | GEO

Microarray analysis of the migrating human CD4+ T cell population from the spleen of humanized mice in response to treatment with Teplizumab or hIg

Project description:In order to identify genes expressed by cells that leave the spleen, the spleens were harvested from untreated reconstituted humanized mice (N=4) and a single cell suspension was prepared . The cultures were treated with either teplizumab (anti human CD3 hOKT3g1(Ala-Ala)) or hIg for 18 hrs in vitro. Splenocytes were also harvested 18 hrs after reconstituted mice (N=4) were treated with teplizumab in vivo. The humanized mice used where NOD/SCID IL2gc-/- (NSG) reconstituted with human CD34+ at birth. Total RNA was obtained form sorted human CD4 splenocytes 18 hours post treatment. Comparsons were made between the treatment groups.

2012-02-27 | E-GEOD-34163 | biostudies-arrayexpress

Nef dimerization defect abrogates HIV viremia and associated immune dysregulation in the Bone Marrow-Liver-Thymus-Spleen (BLTS) humanized mouse model.

Project description:Loss of function mutations in the human immunodeficiency virus (HIV)-negative factor (Nef) gene are associated with reduced viremia, robust T cell immune response, and delayed acquired immunodeficiency syndrome (AIDS) progression in humans. Additionally, in vitro studies have shown that mutations in Nef's dimerization interface may play a significant role in modulating viral replication and impairing host defense. However, in vivo, mechanistic studies on the role of Nef dimerization in HIV infection are lacking. Humanized rodent models with human immune cells are robust platforms for investigating the interactions between HIV and the human immune system. We recently developed the bone marrow-liver-thymus-spleen (BLTS) humanized mouse model, which carries human immune cells, as well as primary and secondary lymphoid tissues that facilitate anti-viral immune responses. Here, we employed the BLTS-humanized mouse model to demonstrate that preventing Nef dimerization abrogates HIV viremia and the associated induction of immune dysregulation (immune activation and exhaustion). This suggests that Nef dimerization may be a therapeutic target for future HIV cure strategies, which can be explored in humanized mouse models.

2021-03-10 | GSE165387 | GEO

Comparison of transcription profile of allogenic immune response generated in MLR and Humanzied mouse model

Project description:This experiment was carried out to demonstrate the efficacy of our novel humanized mouse model for identifying the best potential donor for the recipient. We performed a transcriptome analysis comparing the allogeneic immune response in MLR and the Hu-NSG-PBMC model. We identified several clinically relevant markers of graft rejection, such as GZMB, PRF1, and IL2, were significantly up regulated in one of the related donors only observed in the allogeneic response generated in the humanized mouse model.

2021-04-04 | E-MTAB-10343 | biostudies-arrayexpress

Single cell transcriptional profile of SC-islet grafts in an in vivo humanized model [scRNA-seq_invivo]

Project description:To study immune responses in the context of human allogeneic graft rejection, we chose the Hu-PBL-NSG-MHCnull humanized mouse (Brehm et al., 2019). NOD-scid IL-2 receptor subunit γ (IL2rg)null (NSG) immunocompromised mice that lack murine MHC class I and II, were transplanted (under the kidney capsule, n=12) with 5M SC-islets (HLA-A2 positive), followed by human PBMC injection (termed ‘hPi-mice’; 50M/mouse, n=6) from healthy unmatched donors (HLA-A2 negative). The lack of murine MHC allowed us to monitor the graft function for prolonged durations without the risk of xenogeneic graft vs host disease (GVHD). Half of the SC-islet transplanted cohort (n=6 mice) was used as the control, without PBMC injection (Figure 1A). Since graft elimination by PBMCs is incomplete and residual endocrine cells remain in the hPi-mice grafts, we retrieved the SC-islet grafts for single cell RNA sequencing (scRNA-seq) analysis. These samples, along with pre-injected PBMCs as controls, were used for 10x Genomics mRNA expression library preparation and Illumina sequencing.

2022-09-01 | GSE200083 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data